Eli Lilly sues four telehealth companies selling compounded tirzepatidenews2025-04-23T09:00:39+00:00April 23rd, 2025|Endpoints News|
Recent FDA staff cuts to delay drug hearing decision by months, agency tells Vandanews2025-04-22T18:20:42+00:00April 22nd, 2025|Endpoints News|
Alvogen unit appeals court loss in bid to market Xifaxan genericnews2025-04-21T17:04:09+00:00April 21st, 2025|Endpoints News|
Trump drug price executive order: Winners and losersnews2025-04-16T18:38:40+00:00April 16th, 2025|Endpoints News|
Trump pledges support for changing IRA ‘pill penalty,’ siding with pharmanews2025-04-15T21:36:53+00:00April 15th, 2025|Endpoints News|
Sandoz sues Amgen over nearly decadelong launch delay for Enbrel biosimilarnews2025-04-14T17:32:12+00:00April 14th, 2025|Endpoints News|
Primate researchers gird for funding cuts as NIH fights court blocknews2025-04-14T15:00:31+00:00April 14th, 2025|Endpoints News|
Firings of HHS’ probationary workers can proceed, appeals court saysnews2025-04-09T19:19:23+00:00April 9th, 2025|Endpoints News|
House panel mulls ways to boost struggling biosimilar marketnews2025-04-08T19:18:53+00:00April 8th, 2025|Endpoints News|
NIH appeals nationwide block on indirect cost cutsnews2025-04-08T18:59:16+00:00April 8th, 2025|Endpoints News|
